Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 144,306 | 158,545 | 147,589 | 300,484 | 283,610 |
| Marketable Securities | 57,874 | 79,879 | 98,745 | 145,380 | 210,016 |
| Receivables | 125,635 | 124,069 | 115,268 | 114,367 | 104,745 |
| Inventories | 150,370 | 152,863 | 157,680 | 148,163 | 133,754 |
| TOTAL | $514,961 | $547,974 | $562,751 | $745,613 | $759,962 |
| Non-Current Assets | |||||
| PPE Net | 136,281 | 140,690 | 147,388 | 155,178 | 164,451 |
| Investments And Advances | 22,768 | 22,308 | 20,271 | 18,810 | 28,031 |
| Intangibles | 373,000 | 388,314 | 402,713 | 442,863 | 456,489 |
| Other Non-Current Assets | 161,524 | 165,631 | 164,454 | 174,798 | 177,736 |
| TOTAL | $693,573 | $716,943 | $734,826 | $791,649 | $826,707 |
| Total Assets | $1,208,534 | $1,264,917 | $1,297,577 | $1,537,262 | $1,586,669 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 202,397 | 202,086 |
| Accounts payable and accrued liabilities | 14,012 | 15,150 | 17,687 | 30,124 | 23,172 |
| Accrued Expenses | 84,957 | 95,601 | 79,643 | 71,023 | 80,069 |
| TOTAL | $108,787 | $120,590 | $107,078 | $313,164 | $314,732 |
| Non-Current Liabilities | |||||
| Long Term Debt | 367,656 | 372,189 | 376,721 | 97,828 | 101,489 |
| Other Non-Current Liabilities | 74,105 | 74,814 | 81,977 | 363,920 | 364,911 |
| TOTAL | $445,854 | $451,216 | $463,285 | $466,331 | $473,396 |
| Total Liabilities | $554,641 | $571,806 | $570,363 | $779,495 | $788,128 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,348 | 40,490 | 43,021 | 44,933 | 46,305 |
| Common Shares | 48 | 48 | 48 | 48 | 47 |
| Retained earnings | -196,406 | -199,322 | -200,959 | -206,391 | -201,544 |
| Other shareholders' equity | 3,442 | 4,762 | 4,580 | 4,547 | 1,230 |
| TOTAL | $653,893 | $693,111 | $727,214 | $757,767 | $798,541 |
| Total Liabilities And Equity | $1,208,534 | $1,264,917 | $1,297,577 | $1,537,262 | $1,586,669 |